FR12C0060I2 - Procede de fabrication de vaccins - Google Patents

Procede de fabrication de vaccins

Info

Publication number
FR12C0060I2
FR12C0060I2 FR12C0060C FR12C0060C FR12C0060I2 FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2 FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2
Authority
FR
France
Prior art keywords
manufacturing vaccines
vaccines
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0060C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Priority claimed from GB0526040A external-priority patent/GB0526040D0/en
Priority claimed from PCT/EP2006/006270 external-priority patent/WO2007000343A2/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of FR12C0060I1 publication Critical patent/FR12C0060I1/fr
Application granted granted Critical
Publication of FR12C0060I2 publication Critical patent/FR12C0060I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR12C0060C 2005-06-27 2012-10-18 Procede de fabrication de vaccins Active FR12C0060I2 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526040A GB0526040D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
PCT/EP2006/006270 WO2007000343A2 (en) 2005-06-27 2006-06-23 Process for manufacturing vaccines

Publications (2)

Publication Number Publication Date
FR12C0060I1 FR12C0060I1 (enExample) 2012-12-14
FR12C0060I2 true FR12C0060I2 (fr) 2017-01-06

Family

ID=34856207

Family Applications (1)

Application Number Title Priority Date Filing Date
FR12C0060C Active FR12C0060I2 (fr) 2005-06-27 2012-10-18 Procede de fabrication de vaccins

Country Status (8)

Country Link
CN (4) CN101247827B (enExample)
BE (1) BE2021C560I2 (enExample)
ES (1) ES2367918T5 (enExample)
FR (1) FR12C0060I2 (enExample)
GB (1) GB0513069D0 (enExample)
NO (2) NO2021022I1 (enExample)
UA (1) UA97233C2 (enExample)
ZA (3) ZA200710853B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040914T4 (hu) * 2012-01-30 2019-05-28 Serum Institute Of India Pvt Ltd Immunogén készítmény
HUE049531T2 (hu) * 2012-08-16 2020-10-28 Pfizer Glikokonjugációs eljárások és kompozíciók
AU2017321863B2 (en) * 2016-09-02 2024-07-11 Sanofi Vaccines US Inc. Neisseria meningitidis vaccine
LT3544637T (lt) * 2016-11-25 2021-03-25 Glaxosmithkline Biologicals S.A. Natyvių omv ir antigeno konjugatai bei jų naudojimo būdas
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
WO2021099982A1 (en) * 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
CN115721709A (zh) * 2021-08-27 2023-03-03 康希诺生物股份公司 一种肺炎球菌结合疫苗制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
OA12302A (en) * 2000-06-29 2003-10-24 Glaxosmithkline Biolog Sa Multivalent vaccine composition.
EP1372707A1 (en) * 2001-04-06 2004-01-02 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper

Also Published As

Publication number Publication date
GB0513069D0 (en) 2005-08-03
CN101247827B (zh) 2013-07-17
CN101208101A (zh) 2008-06-25
CN101222935A (zh) 2008-07-16
CN101222935B (zh) 2015-07-29
CN101208103A (zh) 2008-06-25
CN101208101B (zh) 2013-01-02
ES2367918T5 (es) 2014-11-21
CN101208103B (zh) 2013-04-24
NO2025018I1 (no) 2025-04-08
UA97233C2 (uk) 2012-01-25
ZA200711074B (en) 2009-07-29
ZA200710853B (en) 2009-04-29
CN101247827A (zh) 2008-08-20
FR12C0060I1 (enExample) 2012-12-14
BE2021C560I2 (enExample) 2026-02-02
NO2021022I1 (no) 2021-05-25
ZA200710909B (en) 2009-04-29
ES2367918T3 (es) 2011-11-10

Similar Documents

Publication Publication Date Title
IL188072A0 (en) Process for manufacturing vaccines
FR12C0060I2 (fr) Procede de fabrication de vaccins
EP1983636A4 (en) Rotor manufacturing method
EP2074445A4 (en) METHOD FOR PRODUCING AN ADJUSTABLE LENS
FR2902785B1 (fr) Procede de fabrication de 1,2-dichloroethane
GB0700136D0 (en) Process for manufacturing vaccines
FR2870231B1 (fr) Procede de fabrication de vitroceramique
FR2902787B1 (fr) Procede de fabrication de 1,2-dichloroethane
EP1952908A4 (en) FORM PROCESS
EP1887612A4 (en) PROCESS FOR THE PRODUCTION OF A BONDED WAFERS
FR2902786B1 (fr) Procede de fabrication de 1,2-dichloroethane
FR2903983B1 (fr) Procede de fabrication de diesters.
DE602006020716D1 (de) Kastenloses formverfahren
FR2902784B1 (fr) Procede de fabrication de 1,2-dichloroethane
EP1838862A4 (en) METHOD OF PREPARING KAEMPFEROL
DE602006004399D1 (de) Schleifverfahren
EP1925019A4 (en) NANO-FORM PROCESS
FR2876998B1 (fr) Procede de preparation de gamma-liv205
FR2895286B1 (fr) Procede de broyage
EP1867627A4 (en) Process for production of tertiary amines
EP1961699A4 (en) PROCESS FOR THE PREPARATION OF CHLORINE
FR2908423B1 (fr) Procede de fabrication de biere.
FR2865480B1 (fr) Procede de fabrication de surfaces non tissees
FR2894958B1 (fr) Procede de preparation de difluoroethanol
FI20050208L (fi) Menetelmä uusien tuotteiden valmistamiseksi